Dr. Torben Plesner, MD is Professor and Head of the Department of Hematology at the Center Lillebaelt, Vejle Hospital in Denmark. Dr. Plesner is founder of the Clinical Research Unit at the hospital and participates on the council, board, committee and networks for the European Hematology Association and the European Myeloma Network. He has helped evaluate research and early clinical trials for daratumumab since its inception. He is on the council and boards of both the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).
Thanks to our episode sponsor, Takeda Oncology.
about the author
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.